AstraZeneca Reports Mixed Lung Cancer Trial Results

AstraZeneca suffers another setback as it halts volrustomig lung cancer trial

AstraZeneca is stopping a clinical trial of the experimental drug volrustomig as it didn’t look set to help fight lung cancer better than existing therapies. The company had two separate late-stage trial successes that strengthen key cancer franchises, including one where…